We have found 332 companies that use Cepheid GeneXpert. Our data for Cepheid GeneXpert usage goes back as far as 10 months.
70% of Cepheid GeneXpert customers are in United States. Of all the companies that are using Cepheid GeneXpert, a majority (54%) are large (>1000 employees), 14% are small (<50 employees) and 25% are medium-sized. Looking at Cepheid GeneXpert customers by industry, we find that Hospital & Health Care (66%) and Higher Education (8%) are the largest segments.
|Logo||Company||Website||Signal Strength||Scan Date|
|NHS Human Services, Inc.||nhsonline.org||2017-06-16|
|South Shore Hospital, Inc.||southshorehospital.org||2017-06-16|
|Laboratory Corp. of America||labcorp.com||2017-06-16|
|Boston Medical Center Corp.||bmc.org||2017-06-16|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Cepheid GeneXpert has a market share of about 0.5%. Other major and competing products in this category include:
Cepheid's GeneXpert is a fully integrated and automated on-demand molecular diagnostic system. The GeneXpert System is available in a one, two, four, 16, 48, or 80-module configuration. All have Cepheid's proven GeneXpert module at their analytic heart, and use the same patented cartridge technology for every Xpert test.